BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Murata K, Sugimoto K, Shiraki K, Nakano T. Relative predictive factors for hepatocellular carcinoma after HBeAg seroconversion in HBV infection. World J Gastroenterol 2005; 11(43): 6848-6852 [PMID: 16425395 DOI: 10.3748/wjg.v11.i43.6848]
URL: https://www.wjgnet.com/1007-9327/full/v11/i43/6848.htm
Number Citing Articles
1
R. Iorio, A. Giannattasio, F. Cirillo, L. D'Alessandro, A. Vegnente. Long-Term Outcome in Children with Chronic Hepatitis B: A 24-Year Observation PeriodClinical Infectious Diseases 2007; 45(8): 943 doi: 10.1086/521864
2
Takashi Kumada, Hidenori Toyoda, Seiki Kiriyama, Yasuhiro Sone, Makoto Tanikawa, Yasuhiro Hisanaga, Akira Kanamori, Hiroyuki Atsumi, Makiko Takagi, Takahiro Arakawa, Masashi Fujimori. Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase valuesJournal of Medical Virology 2010; 82(4): 539 doi: 10.1002/jmv.21686
3
S. K. Basnayake, P. J. Easterbrook. Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literatureJournal of Viral Hepatitis 2016; 23(7): 545 doi: 10.1111/jvh.12519
4
M. J. Tong, C. Q. Pan, S.‐H. B. Han, D. S.‐K. Lu, S. Raman, K.‐Q. Hu, J. K. Lim, H. W. Hann, A. D. Min. An expert consensus for the management of chronic hepatitis B in Asian AmericansAlimentary Pharmacology & Therapeutics 2018; 47(8): 1181 doi: 10.1111/apt.14577
5
Kenichi Ito, Makoto Arai, Fumio Imazeki, Yutaka Yonemitsu, Dan Bekku, Tatsuo Kanda, Keiichi Fujiwara, Kenichi Fukai, Kenichi Sato, Sakae Itoga, Fumio Nomura, Osamu Yokosuka. Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus InfectionScandinavian Journal of Gastroenterology 2010; 45(2): 243 doi: 10.3109/00365520903450113
6
Evangelista Sagnelli, Mariantonietta Pisaturo, Salvatore Martini, Pietro Filippini, Caterina Sagnelli, Nicola Coppola. Clinical impact of occult hepatitis B virus infection in immunosuppressed patientsWorld Journal of Hepatology 2014; 6(6): 384-393 doi: 10.4254/wjh.v6.i6.384
7
Noboru Shinkai, Yasuhito Tanaka, Kiyoaki Ito, Motokazu Mukaide, Izumi Hasegawa, Yasuhiro Asahina, Namiki Izumi, Hiroshi Yatsuhashi, Etsuro Orito, Takashi Joh, Masashi Mizokami. Influence of Hepatitis B Virus X and Core Promoter Mutations on Hepatocellular Carcinoma among Patients Infected with Subgenotype C2Journal of Clinical Microbiology 2007; 45(10): 3191 doi: 10.1128/JCM.00411-07
8
Dan Bekku, Makoto Arai, Fumio Imazeki, Yutaka Yonemitsu, Tatsuo Kanda, Keiichi Fujiwara, Kenichi Fukai, Kenichi Sato, Sakae Itoga, Fumio Nomura, Osamu Yokosuka. Long‐term follow‐up of patients with hepatitis B e antigen negative chronic hepatitis BJournal of Gastroenterology and Hepatology 2011; 26(1): 122 doi: 10.1111/j.1440-1746.2010.06322.x
9
T.‐C. Zhou, X. Lai, M.‐H. Feng, Y. Tang, L. Zhang, J. Wei. Systematic review and meta‐analysis: Development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis e antigen seroconversionJournal of Viral Hepatitis 2018; 25(10): 1172 doi: 10.1111/jvh.12928